This lecture was presented on April 11, 2019 at the 13th Annual American Conference for the Treatment of HIV (ACTHIV).

Release Date: September 15, 2019  -  Expiration Date: September 15, 2020

The enduring material is jointly provided by Beaumont Health, American Academy of CME, Inc., and the American Conference for the Treatment of HIV (ACTHIV).  The Conference was supported by the Clinical Education Initiative, New York State Department of Health, AIDS Institute. The conference and this web archive were supported by educational grants from Gilead Sciences; Janssen Therapeutics, Division of Janssen Products, LP; Merck & Co., and ViiV HealthCare.

There is no fee to participate in this activity.

Click here to access the presentation.

1. Individualize initial antiretroviral therapy for a person with HIV infection
2. Evaluate new options for treating HIV

This activity has been planned and implemented in accordance with the accreditation requirements and policies of the Accreditation Council for Continuing Medical Education through the joint providership of Beaumont Health, American Academy of CME, Inc., and the American Conference for the Treatment of HIV (ACTHIV).  Beaumont Health is accredited by the ACCME to provide continuing medical education for physicians.

Physicians:

Beaumont Health designates this enduring material for a maximum of 0.5 AMA PRA Category 1 Credit(s)™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.

In support of improving patient care, this activity has been planned and implemented by American Academy of CME, Inc., Beaumont Health, and the American Conference for the Treatment of HIV (ACTHIV). American Academy of CME, Inc. is Jointly accredited by the Accreditation Council for Continuing Medical Education (ACCME), the Accreditation Council for Pharmacy Education (ACPE), and the American Nurses Credentialing Center (ANCC), to provide continuing education for the healthcare team.

Nurses Practitioners and Nurse:

American Academy of CME, Inc. is accredited as a provider of continuing nursing education by the American Nurses Credentialing Center’s Commission on Accreditation.

American Academy of CME, Inc. designates this educational activity for 0.5 contact hours (0.5 pharmacotherapeutic contact hours).

Physician Assistants:

American Academy of CME, Inc. has been authorized by the American Academy of PAs (AAPA) to award AAPA Category 1 CME credit for activities planned in accordance with AAPA CME Criteria. This activity is designated for 0.5 AAPA Category 1 CME credits. Approval is valid until September 15, 2020. PAs should only claim credit commensurate with the extent of their participation.

All other members of the HIV Care team will receive a certificate of participation.

TARGET AUDIENCE

Members of the HIV care team who are frontline providers of care to persons at risk of or with HIV infection, including physicians (both specialists and primary care/family medicine), nurse practitioners, physician assistants, nurses. Pharmacists, case managers and other healthcare professionals are also encouraged to participate.

No faculty are available for this activity at this time.